Over-the-counter continuous glucose monitors have gained popularity over recent years. These devices are designed to help ...
FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, ...
DXCM's redesigned Stelo app is set for a July U.S. rollout, with international expansion and pediatric clearance broadening ...
Medical Device Network on MSN
FDA clears Dexcom’s Stelo as first OTC glucose monitor for children
The FDA’s indication expansion for Dexcom’s Stelo makes it the first over the counter CGM available for children, including ...
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of ...
Dexcom has received Food and Drug Administration clearance for the first over-the-counter glucose sensor for children. The ...
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users ...
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
Zacks Investment Research on MSN
DXCM receives FDA clearance for Stelo OTC CGM system for children
DexCom DXCM received FDA clearance for its Stelo Glucose Biosensor System for use in children aged two years and older who do ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
DexCom will roll out its redesigned Stelo app in the United States starting in July. Stelo is expected to launch in four international markets later this year, with more expansion to 2027. DexCom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results